EV71 vaccine: Phase III started

Sinovac began a double-blind, placebo-controlled, Chinese Phase III trial to evaluate 2 doses of 400U EV71 plus an aluminum adjuvant given 28 days apart in up to 10,000 healthy infants ages 6-35 month...